Material Agreements

HERTZ GLOBAL HOLDINGS, INC amended Amendment No. 8 to Credit Agreement with Barclays Bank PLC (effective 2024-04-16).

“On April 16, 2024, The Hertz Corporation (“THC”) entered into Amendment No. 8 to Credit Agreement (“Amendment No. 8”), by and among THC, the Subsidiary Borrowers (as defined below) party thereto, Rental Car Intermediate Holdings, LLC, the other guarantors party thereto and Barclays Bank PLC, as administrative agent (the “Administrative Agent”) and the Revolving Lenders party thereto, which amends that certain Credit Agreement, dated as of June 30, 2021, by and among THC, the subsidiary borrowers party thereto from time to time (the “Subsidiary Borrowers”), the several lenders and issuing lenders from time to time party thereto, the Administrative Agent, and Barclays Bank PLC, as collateral agent”

James River Group Holdings, Inc. amended Fourth Amendment to the Credit Agreement with BMO Bank N.A. (effective 2024-04-16).

“(ii) the Fourth Amendment (the "BMO Amendment") to the Credit Agreement dated as of August 2, 2017, as amended, (the "BMO Facility") by and among the Company, as borrower, and BMO Bank N.A., as the lender ("BMO")”

James River Group Holdings, Inc. amended First Amendment to the Third Amended and Restated Credit Agreement with KeyBank National Association (effective 2024-04-16).

“On April 16, 2024, James River Group Holdings, Ltd. (the "Company") entered into (i) the First Amendment (the "KeyBank Amendment") to the Third Amended and Restated Credit Agreement dated as of July 7, 2023 (the "KeyBank Facility") by and among the Company, as borrower, KeyBank National Association ("KeyBank") as Administrative Agent and Letter of Credit Issuer, KeyBank and Truist Securities, Inc. as Joint Book Runners and Joint Lead Arrangers, Truist Bank as Syndication Agent, and the lender parties thereto (the "KeyBank Lenders")”

REALLOYS INC. entered into Contribution Agreement with Blackbox.io Inc. (effective 2024-04-18).

“On April 18, 2024, the Company and Blackbox Operating entered into a contribution agreement (the “Contribution Agreement”) in which the Company transferred certain specified assets of the Business (the “Contributed Assets”) to Blackbox Operating.”

Shepherd's Finance, LLC amended Amendment No. 4 to the Second Amended and Restated Limited Liability Company Agreement (effective 2024-03-31).

“On April 19, 2024, Shepherd’s Finance, LLC (the “Registrant”) entered into Amendment No. 4 to the Second Amended and Restated Limited Liability Company Agreement, as amended (the “Fourth Amendment”), with an effective date of March 31, 2024 (the “Effective Date”), to effect a 100-for-1 unit split (the “Unit Split”) of its Series C Cumulative Preferred Units”

Oportun Financial Corp entered into Agreement with Findell Capital Management LLC and certain of its affiliates (effective 2024-04-19).

“On April 19, 2024, Oportun Financial Corporation (the “Company”) entered into a letter agreement (the “Agreement”) with Findell Capital Management LLC and certain of its affiliates (collectively, “Findell”).”

Propanc Biopharma, Inc. entered into Purchase Agreement with an investor (the “Investor”) valued at aggregate principal amount of $27,500 (effective 2024-04-16).

“Effective April 16, 2024, Propanc Biopharma, Inc. (the “Company”) entered into and closed a securities purchase agreement (the “Purchase Agreement”) with an investor (the “Investor”), pursuant to which the Investor agreed to purchase a convertible promissory note from the Company in the aggregate principal amount of $27,500 (the “Note”), for a purchase price of $25,000.”

New Asia Holdings, Inc. entered into Share Exchange Agreement with Olenox Corp. and Marble Trital Inc. (effective 2024-04-16).

“On April 16, 2024, New Asia Holdings, Inc. (the “Company”) entered into a Share Exchange Agreement (the “Exchange Agreement”) by and between the Company, Olenox Corp., a Wyoming corporation (“Olenox”), and Marble Trital Inc., as the sole shareholder of Olenox (the “Shareholder”). Pursuant to the terms of the Exchange Agreement, the Company agreed to acquire from the Shareholder all of the issued and outstanding shares of common stock, par value $0.0001 per share, of Olenox in exchange for the issuance by the Company to the Shareholder of 224,305,833 shares of common stock, par value $0.001 per share, of the Company.”

Nixxy, Inc. amended Amendment to Technology License and Commercialization Agreement with GoLogiq, Inc. valued at Added Section 3.3 on technical assistance; amended royalty from 8% to 5%; Company agreed to grant wa (effective 2024-03-28).

“On March 28, 2024 (the “Effective Date”), the Company and GOLQ entered into an Amendment to Technology License and Commercialization Agreement (the “Amendment”). Under the Amendment, the Company and GOLQ agreed to and added Section 3.3 to further detail technical assistance from GOLQ to the Company. In addition, Section 5.1 was amended such that the royalty was lowered from eight percent (8%) to five percent (5%) for which the Company agreed to grant GOLQ a warrant (the “Warrant”) to purchase two hundred ninety-two thousand (292,000) shares of Company Common Stock (the “Warrant Shares”) for a price equal to $0.01 per share (the “Exercise Price”).”

Nixxy, Inc. entered into Technology License and Commercialization Agreement with GoLogiq, Inc. valued at Worldwide exclusive license of fintech technology (Createapp, Paylogiq, Gologiq, Radix AI) for 10-ye (effective 2024-02-23).

“On February 23, 2024, the Company entered into a certain Technology License and Commercialization Agreement (the “GOLQ Licensing Agreement”) with GoLogiq, Inc. (“GOLQ”) whereby GOLQ grants the Company a worldwide, exclusive license (the “GOLQ License”) to the Company to develop its fintech technology (the “GOLQ Technology”) and sell products derived thereof, including its Createapp, Paylogiq, Gologiq, and Radix AI technology and products (the “Licensed Products”), for a term of 10 years, with automatic two (2) year renewals as further described therein (the “Term”).”

SPIRITS TIME INTERNATIONAL, INC. amended Amendment to Promissory Note with Auctus Fund, LLC valued at $339,023.00 outstanding ($290,000 principal + $49,023 interest); monthly interest $5,800 (effective 2024-04-12).

“On April 16, 2024, the parties completed execution of an amendment to the Note (the “Amendment”) effective as of April 12, 2024 (the “Effective Date”).”

Quanex Building Products CORP entered into Commitment Letter with certain financial institution parties named therein (effective 2024-04-21).

“the Company and certain financial institution parties named therein entered into a commitment letter, dated as of April 21, 2024 (the “ Commitment Letter ”)”

Quanex Building Products CORP entered into Interim Facility Agreement with Wells Fargo Securities, LLC, BofA Securities, Inc. and TD Bank, N.A. (effective 2024-04-21).

“the Company, as guarantor and borrower, entered into an interim facility agreement, dated as of April 21, 2024 (the “ Interim Facility Agreement ”), with Wells Fargo Securities, LLC, BofA Securities, Inc. and TD Bank, N.A. as arrangers and Wells Fargo Bank, National Association, as interim facility agent and interim security agent”

Quanex Building Products CORP entered into Co-operation Agreement with Tyman plc (effective 2024-04-22).

“oard ”) and Tyman plc, a company incorporated in England and Wales (“ Tyman ”) (the “ Tyman Board ”), had reached an agreement on the terms of a recommended acquisition of Tyman by the Company (the “ Transaction ”).”

COHEN & STEERS, INC. entered into ATM Equity Offering Sales Agreement with BofA Securities, Inc. valued at $100,000,000 (effective 2024-04-22).

“On April 22, 2024, Cohen & Steers, Inc. (the “Company”) entered into an ATM Equity Offering Sales Agreement (the “Sales Agreement”) with BofA Securities, Inc. (“BofA Securities”), pursuant to which the Company may offer and sell, from time to time, shares of its common stock, par value $0.01 per share (the “Shares”) having an aggregate offering price of up to $100,000,000 through BofA Securities, acting as its agent, or directly to BofA Securities, acting as principal.”

EQUITY BANCSHARES INC entered into Agreement and Plan of Merger with Kansasland Bancshares, Inc. valued at $100,000 (effective 2024-04-18).

“entered into an Agreement and Plan of Merger (the “Agreement”), by and among the Company, KL Merger Sub, Inc. (“Merger Sub”), a Kansas corporation and a wholly owned subsidiary of the Company, Kansasland Bancshares, Inc. (“Kansasland”), a Kansas corporation and the parent company of KansasLand Bank (“KansasLand Bank”), a Kansas state bank.”

TD SYNNEX CORP entered into Term Loan Credit Agreement with Bank of America, N.A. valued at $750 million (effective 2024-04-19).

“On April 19, 2024, TD SYNNEX entered into a Term Loan Credit Agreement (the “New Term Loan Credit Agreement” and, together with the Amended and Restated Credit Agreement, the “Credit Agreements”) with the initial lenders party thereto, Bank of America, N.A. (“Bank of America”), as administrative agent for the lenders, and BOFA Securities, Inc., as lead arranger and lead bookrunner.”

TD SYNNEX CORP amended Amended and Restated Credit Agreement with Citibank, N.A. valued at $3.5 billion (effective 2024-04-16).

“On April 16, 2024, TD SYNNEX Corporation (“TD SYNNEX”) entered into an Amended and Restated Credit Agreement (the “Amended and Restated Credit Agreement”) with TD SYNNEX UK Acquisition Limited as a designated borrower, the initial lenders party thereto, and Citibank, N.A. (“Citibank”), as administrative agent for the lenders.”

BRUKER CORP entered into Asset Purchase Agreement with NanoString Technologies, Inc. valued at $392.6 million (effective 2024-04-17).

“On April 17, 2024, Bruker Corporation (the “Company”) entered into an Asset Purchase Agreement (the “Asset Purchase Agreement”) with NanoString Technologies, Inc., a Delaware corporation (“Seller”), as the result of the Company being selected as the successful bidder in a sale authorized by the United States Bankruptcy Court for the District of Delaware (the “Bankruptcy Court”) pursuant to, inter alia, sections 105, 363, and 365 of the United States Bankruptcy Code (the “Bankruptcy Code”).”

COSTAR GROUP, INC. entered into Agreement and Plan of Merger and Reorganization with Matterport, Inc. (effective 2024-04-21).

“On April 21, 2024, CoStar Group, Inc., a Delaware corporation (“CoStar”), entered into an Agreement and Plan of Merger and Reorganization (the “Merger Agreement”) with Matterport, Inc.”

LSI INDUSTRIES INC entered into Asset Purchase Agreement with EMI Industries, LLC valued at $50 million (effective 2024-04-18).

“On April 18, 2024, EMI Acquisition Company Inc., an Ohio corporation (“ Purchaser ”), and wholly owned subsidiary of LSI Industries Inc., an Ohio corporation (“ LSI ” or the “ Company ”), EMI Industries, LLC, a Florida limited liability company (“ EMI ” or “ Seller ”), LSI (with respect to Section 7.11’s Parent guaranty provisions) and certain members of Seller made parties thereto (the “ Majority Members ”) entered into an Asset Purchase Agreement (the “ Purchase Agreement ”) pursuant to which Seller agreed to sell substantially all of its assets to Purchaser for an aggregate cash purchase price of $50 million, subject to a working capital adjustment.”

BNB PLUS CORP. entered into Warrant Amendments with certain holders valued at $0.609 per Warrant (effective 2024-04-16).

“On April 16, 2024, the Company entered into amendments to certain outstanding warrants (“Warrants”) to purchase shares of the Company’s common stock”

CADIZ INC entered into Solstra Agreement with Solstra Communities California LLC valued at approximately $16 million (effective 2024-04-18).

“On April 18, 2024, Cadiz Inc. (the “Company” or “Cadiz”) and Fenner Gap Mutual Water Company entered into a water supply agreement with Solstra Communities California LLC (“Solstra”), a California limited liability company and the owner of private land in southern California pursuing the development of up to 4,000 workforce housing units and ancillary commercial infrastructure (“Solomon Hills”) that would serve the Vandenburg Air Force Base community (“Solstra Agreement”).”

KAMAN Corp terminated Existing Credit Agreement with JPMorgan Chase Bank, N.A. valued at Repaid in full all outstanding loans and terminated all commitments (effective 2024-04-19).

“On April 19, 2024, in connection with the consummation of the Merger, the Company repaid in full all outstanding loans, together with interest and all other amounts due in connection with such repayment, under that certain Third Amended and Restated Credit Agreement, dated as of June 21, 2023 among the Company, certain subsidiaries of the Company, the lenders party thereto from time to time, and JPMorgan Chase Bank, N.A., as administrative agent and collateral agent (as amended, modified or otherwise supplemented) (the “ Existing Credit Agreement ”), and terminated all commitments thereunder.”

KAMAN Corp entered into Second Supplemental Indenture with U.S. Bank National Association valued at Amendment to Indenture for 3.25% Convertible Senior Notes due 2024; conversion right changed to Refe (effective 2024-04-19).

“On April 19, 2024, in connection with the consummation of the Merger, the Company entered into a Second Supplemental Indenture (the “ Second Supplemental Indenture ”), among the Company, Parent and U.S. Bank National Association (as successor-in-interest to U.S. Bank National Association), a national banking association, as trustee (the “ Trustee ”), to the Indenture, dated as of May 12, 2017 (the “ Original Indenture ”), between the Company and the Trustee, as supplemented by the First Supplemental Indenture, dated as of July 15, 2019 (the “ First Supplemental Indenture ” and, together with the Original Indenture and the Second Supplemental Indenture, the “ Indenture ”), between the Company and the Trustee, relating to the Company’s 3.25% Convertible Senior Notes due 2024 (the “ Convertible Senior Notes ”).”

KAMAN Corp entered into New Credit Agreement with Morgan Stanley Senior Funding, Inc. valued at $815,000,000 senior secured term loan facility; $150,000,000 senior secured revolving credit facilit (effective 2024-04-19).

“On April 19, 2024, Parent, as the borrower, and Ovation Parent Holdings, Inc., a Delaware corporation (“ Holdings ”), entered into that certain Credit Agreement with Morgan Stanley Senior Funding, Inc., as administrative agent, collateral agent, a joint lead arranger and a joint bookrunner, the lenders and L/C issuers from time to time party thereto and the other parties from time to time party thereto (the “ New Credit Agreement ”), which provides for (i) an initial senior secured term loan facility in an aggregate principal amount equal to $815,000,000 and (ii) an initial senior secured revolving credit facility in an aggregate principal amount equal to $150,000,000, which includes a letter of credit sub-facility in an amount equal to $75,000,000.”

Aon plc entered into Amendment No. 4 with Citibank, N.A. valued at Amendment to 2021 Revolving Credit Agreement (effective 2024-04-16).

“(ii) Amendment No. 4 (“Amendment No. 4” and, together with Amendment No. 1 and Amendment No. 2, the “Amendments”) to the Credit Agreement dated September 28, 2021 (as amended, supplemented or otherwise modified from time to time, the “2021 Revolving Credit Agreement” and, together with the 2023 Revolving Credit Agreement, the “Revolving Credit Agreements”; the Revolving Credit Agreements together with the Term Loan Credit Agreement, the “Credit Agreements”), by and among Parent, AGL, AGH, Aon Corp, ANA, Aon UK Limited, Citibank, as administrative agent, and the lenders party thereto from time to time.”

Aon plc entered into Amendment No. 2 with Citibank, N.A. valued at Amendment to 2023 Revolving Credit Agreement (effective 2024-04-16).

“Also on April 16, 2024, Aon Corp, in its capacity as Borrower Representative under each of the Revolving Credit Agreements (as defined below), entered into (i) Amendment No. 2 (“Amendment No. 2”) to the Credit Agreement dated as of October 19, 2023 (as amended, supplemented or otherwise modified from time to time, the “2023 Revolving Credit Agreement”), by and among Parent, AGL, AGH, Aon Corp, ANA, Citibank, as administrative agent, and the lenders party thereto from time to time”

Aon plc entered into Amendment No. 1 with Citibank, N.A. valued at Amendment to Term Loan Credit Agreement (effective 2024-04-16).

“On April 16, 2024, Aon North America, Inc. (“ANA”) entered into Amendment No. 1 (“Amendment No. 1”) to the Term Loan Credit Agreement dated as of February 16, 2024 (as amended, supplemented or otherwise modified from time to time, the “Term Loan Credit Agreement”), by and among ANA, Aon plc (“Parent”), Aon Corporation (“Aon Corp”), Aon Global Holdings plc (“AGH”), Aon Global Limited (“AGL”), Citibank, N.A. (“Citibank”), as administrative agent, and the lenders party thereto from time to time.”

U.S. GOLD CORP. entered into Securities Purchase Agreement with certain investors valued at approximately $4.9 million (effective 2024-04-15).

“On April 15, 2024, U.S. Gold Corp., a Nevada corporation (the “Company”), entered into a Securities Purchase Agreement with certain investors (the “Securities Purchase Agreement”) providing for the issuance and sale by the Company in a registered direct offering (the “Offering”) an aggregate of 1,400,000 shares of the Company’s common stock, $0.001 par value per share (“Common Stock”) at a purchase price of $3.50 per share (the “Offering Shares”).”

Bridgecrest Auto Funding LLC entered into Underwriting Agreement with Citigroup Global Markets Inc., on behalf of itself and as representative of the several underwriters (effective 2024-04-17).

“On April 17, 2024, Bridgecrest Auto Funding LLC (“BAF”) and Bridgecrest Acceptance Corporation (“BAC”) entered into an Underwriting Agreement (the “Underwriting Agreement”) with Citigroup Global Markets Inc., on behalf of itself and as representative of the several underwriters (collectively, the “Underwriters”), for the sale of the following notes to be issued by Bridgecrest Lending Auto Securitization Trust 2024-2 (the “Issuer”): the Class A-1 5.576% Auto Loan Asset Backed Notes, Class A-2 5.78% Auto Loan Asset Backed Notes, Class A-3 5.84% Auto Loan Asset Backed Notes, the Class B 5.94% Auto Loan Asset Backed Notes, the Class C 6.07% Auto Loan Asset Backed Notes and the Class D 6.30% Auto Loan Asset Backed Notes (collectively, the “Publicly Registered Notes”).”

ProSomnus, Inc. entered into Additional Notes with certain existing ProSomnus investors valued at $2,000,000 aggregate principal amount (effective 2024-04-17).

“On April 17, 2024, ProSomnus, Inc. (the “Company”) issued and sold to certain existing ProSomnus investors $2,000,000 aggregate principal amount of the Company’s Senior Secured Convertible Notes due December 6, 2025 (the “Additional Notes”) related to that certain Indenture, dated December 6, 2022, as supplemented by the First Supplemental Indenture entered into on June 29, 2023 (the “First Supplemental Indenture”) and the Second Supplemental Indenture entered into on September 20, 2023 (the “Second Supplemental Indenture”), by and among the Company, ProSomnus Holdings, Inc. and ProSomnus Sleep Technologies, Inc., as guarantors (the “Subsidiary Guarantors”), and Wilmington Trust, National Association, as trustee and collateral agent (as so supplemented, the “Indenture”).”

ARES STRATEGIC INCOME FUND amended A&R Credit Facility with JPMorgan Chase Bank, N.A. valued at aggregate commitment from $800.0 million to $1.75 billion (effective 2024-04-15).

“On April 15, 2024, Ares Strategic Income Fund (the “Fund”) amended and restated its senior secured credit agreement with JPMorgan Chase Bank, N.A. who serves as administrative agent and the lenders party thereto (as amended and restated, the “A&R Credit Facility”).”

D-Wave Quantum Inc. entered into Sixth Amendment to Loan and Security Agreement with PSPIB Unitas Investments II Inc. valued at Additional $30 million prepayment exemption plus $20 million prepayment premium exemption (effective 2024-04-16).

“On April 16, 2024, D-Wave Quantum Inc. (the “Company”) entered into the Sixth Amendment to Loan and Security Agreement (the “Amendment”) with PSPIB Unitas Investments II Inc. (“PSPIB”) amending certain provisions to the Loan and Security Agreement dated as of April 13, 2023, by and among the Company and its subsidiaries and PSPIB, as amended (the “Term Loan”).”

Calidi Biotherapeutics, Inc. entered into Purchase Agreement with each purchaser identified on the signature pages thereto valued at aggregate gross proceeds of approximately $6.077 million (effective 2024-04-16).

“On April 16, 2024, Calidi Biotherapeutics, Inc. (“we,” “our,” or the “Company”) agreed to sell in a public offering an aggregate of 13,232,500 Common Stock Units and 1,965,000 Pre-Funded Warrant Units (“PFW Units”) at an effective combined purchase price of $0.40 per Common Stock Unit or PFW Unit for aggregate gross proceeds of approximately $6.077 million before deducting placement agent fees and offering expenses payable by the Company (the “Offering”).”

QT IMAGING HOLDINGS, INC. terminated Management Services Agreement with QT Imaging Center, a California sole proprietorship of John C. Klock, M.D. (effective 2024-04-01).

“As previously disclosed as Exhibit 10.23 to the Company’s Registration Statement on Form S-4 filed with the Securities and Exchange Commission (the “ SEC ”) on February 7, 2023, QT Imaging, Inc. entered into a Management Services Agreement (the “ MSA ”) with the Practice, dated as of September 1, 2020, as amended by the First Amendment to the MSA, dated June 1, 2021, and the Second Amendment, dated September 21, 2021, pursuant to which the Practice was engaged to provide medical services to the Company and the Company was engaged to provide management services to the Practice. Notice of the parties’ mutual decision to terminate the MSA, in accordance with Section 5.2(c) thereof, was delivered on March 22, 2024 and acknowledged by the Practice on April 17, 2024 with an effective date of April 1, 2024.”

QT IMAGING HOLDINGS, INC. entered into Space and Equipment Sublease with QT Imaging Center, a California sole proprietorship of John C. Klock, M.D. valued at $5,666 rental fee (effective 2024-04-17).

“On April 17, 2024, QT Imaging Holdings, Inc., a Delaware Corporation (the “ Company ”), entered into a Space and Equipment Sublease Agreement (the “ Space and Equipment Sublease ”) with QT Imaging Center, a California sole proprietorship of John C. Klock, M.D. (the “ Practice ”), pursuant to which the Practice will sublease certain medical equipment and space, currently leased from Hamilton Landing Novato LLC by the Company, to the Practice for use in its operations, on a full-time and exclusive basis.”

Benitec Biopharma Inc. entered into Voting Commitment Agreement with the Purchasers valued at Company obligated to use reasonable best efforts to obtain stockholder approval for exercise of Pre- (effective 2024-04-22).

“In connection with the Private Placement, the Company intends to enter into a Voting Commitment Agreement with the Purchasers on the Closing Date (the “Voting Commitment Agreement”).”

Benitec Biopharma Inc. entered into Registration Rights Agreement with the Purchasers valued at Company agrees to file a registration statement covering resale of Registrable Securities by 30th ca (effective 2024-04-22).

“In connection with the closing of the Private Placement, on the Closing Date, the Company will enter into a registration rights agreement (the “Registration Rights Agreement”) with the Purchasers, pursuant to which the Company will agree to register for resale the Shares and the Warrant Shares held by the Purchasers (the “Registrable Securities”).”

Benitec Biopharma Inc. entered into Securities Purchase Agreement with institutional accredited investors valued at aggregate gross proceeds of approximately $40.0 million for 5,749,152 shares at $4.80 per share and (effective 2024-04-17).

“On April 17, 2024, Benitec Biopharma Inc. (the “Company”) entered into a securities purchase agreement (the “Securities Purchase Agreement”) with certain institutional accredited investors named therein (the “Purchasers”), pursuant to which the Company agreed to issue and sell to the Purchasers in a private placement (the “Private Placement”), (i) an aggregate of 5,749,152 shares (the “Shares”) of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), at a purchase price of $4.80 per share and (ii) in lieu of shares of Common Stock to certain Purchasers, pre-funded warrants (the “Pre-Funded Warrants”) to purchase up to an aggregate of 2,584,239 shares of Common Stock (the “Warrant Shares”) at a purchase price of $4.7999 per Pre-Funded Warrant (representing the $4.80 per Share purchase price less the exercise price of $0.0001 per Pre-Funded Warrant Share).”

APi Group Corp entered into Underwriting Agreement with Citigroup Global Markets Inc., BofA Securities, Inc. and UBS Securities LLC, as representatives of the several underwriters valued at $37.50 per share (effective 2024-04-16).

“On April 16, 2024, APi Group Corporation (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Citigroup Global Markets Inc., BofA Securities, Inc. and UBS Securities LLC, as representatives of the several underwriters named in Schedule II thereto (collectively, the “Underwriters”), relating to the underwritten public offering (the “Offering”) of 11,000,000 shares of the Company’s common stock, par value $0.0001 per share (the “Shares”), at a public offering price of $37.50 per share.”

ZeroStack Corp. entered into Stock Purchase Agreement with TruHC Holding GmbH (the "Seller") valued at $6.4 million (effective 2024-04-16).

“On April 16, 2024, Flora Growth Corp. (the "Company") entered into a Stock Purchase Agreement (the "Purchase Agreement") with TruHC Holding GmbH (the "Seller") pursuant to which the Company will acquire all of the issued and outstanding shares of TruHC Pharma GmbH in exchange for 2,770,562 common shares of the Company valued at an aggregate of $6.4 million (the "Purchase Price") based on the closing price of the Company's common shares on March 28, 2024 of $2.31 per share.”

American Bitcoin Corp. entered into At Market Issuance Sales Agreement with B. Riley Securities, Inc., Ladenburg Thalmann & Co. Inc., Kingswood Investments, a division of Kingswood Capital Partners, LLC, PI Financial (US) Corp. and ATB Capital Markets USA Inc. valued at Aggregate offering price up to $70,000,000 of common stock (effective 2024-04-19).

“On April 19, 2024, Gryphon Digital Mining, Inc., a Delaware corporation (the “Company”), entered into an At Market Issuance Sales Agreement (the “ATM Agreement”) with B. Riley Securities, Inc., Ladenburg Thalmann & Co. Inc., Kingswood Investments, a division of Kingswood Capital Partners, LLC, PI Financial (US) Corp. and ATB Capital Markets USA Inc. as agents (the “Sales Agents”), a Terms Agreement with B. Riley Securities, Inc. and a Terms Agreement with Ladenburg Thalmann & Co. Inc. (each, a “Terms Agreement” and together with the ATM Agreement, the “Sales Agreement”), pursuant to which the Company may issue and sell shares of its common stock, $0.0001 par value per share, having an aggregate offering price of up to $70,000,000 (the “Shares”), from time to time through or to the Sales Agents (the “Offering”).”

ATIF Holdings Ltd entered into Securities Purchase Agreement with a non-U.S. investor named in the Purchase Agreement (the "Purchaser") (effective 2024-04-16).

“On April 16, 2024, ATIF Holdings Limited (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with a non- U.S investor named in the Purchase Agreement (the “Purchaser”), pursuant to which the Company agreed to sell an aggregate of 1,092,512 newly issued ordinary shares of the Company, $0.001 par value per ordinary share (the “Ordinary Shares”) at a purchase price of $1.23 per share (the “Private Placement”).”

Canopy Growth Corp terminated Investor Rights Agreement with CBG Holdings LLC and Greenstar Canada Investment Limited Partnership valued at Termination of second amended and restated investor rights agreement (effective 2024-04-18).

“In accordance with the Consent Agreement and as a result of the CBI Exchange, on April 18, 2024, CBG, Greenstar and Canopy Growth terminated the Investor Rights Agreement, along with an administrative services agreement, a co-development agreement and all other commercial arrangements between them and their subsidiaries, other than the Consent Agreement, certain termination agreements and the Exchange Agreement .”

Canopy Growth Corp entered into Exchange Agreement with Greenstar Canada Investment Limited Partnership valued at Exchange of C$81.2 million principal amount of promissory note into 9,111,549 Exchangeable Shares; c (effective 2024-04-18).

“On April 18, 2024, in connection with the approval of the Exchangeable Shares Resolution and the creation of the Exchangeable Shares, the Company entered into an Exchange Agreement (the “ Exchange Agreement ”) with Greenstar Canada Investment Limited Partnership (“ Greenstar ”) , a wholly owned subsidiary of Constellation Brands, Inc. (“ CBI ”), pursuant to which Greenstar converted approximately C$81.2 million of principal amount of the C$100 million principal amount promissory note issued to Greenstar by Canopy Growth on April 14, 2023 (the “ Promissory Note ”) into 9,111,549 Exchangeable Shares (the “ Note Exchange ”), calculated based on a price per Exchangeable Share equal to C$8.91.”

Greenbrook TMS Inc. entered into thirtieth amendment to credit agreement with Madryn Fund Administration, LLC valued at US$2,030,457 borrowed, aggregate principal outstanding approx. US$96 million (effective 2024-04-15).

“On April 15, 2024, the Company entered into the thirtieth amendment (the " Amendment ") to the Company’s credit agreement, dated as of July 14, 2022 (as previously amended and as amended by the Amendment, the " Credit Agreement "), by and among the Company, certain of its subsidiaries party thereto as guarantors, Madryn Fund Administration, LLC, as administrative agent (" Madryn ") and the lenders party thereto.”

NRX Pharmaceuticals, Inc. entered into Underwriting Agreement with EF Hutton LLC valued at approximately $2.0 million (effective 2024-04-18).

“On April 18, 2024, NRx Pharmaceuticals, Inc. (the “ Company ”) entered into an underwriting agreement (the “ Underwriting Agreement ”) with EF Hutton LLC (the “ Representative ”), as the representative of the several underwriters named therein (the “ Underwriters ”), relating to an underwritten public offering (the “ Offering ”) of 607,000 shares (the “ Shares ”) of the Company’s common stock, par value $0.001 per share (“ Common Stock ”).”

Datavault AI Inc. entered into Second Transaction Purchase Agreement with certain purchasers valued at aggregate gross proceeds of approximately $1.9 million (effective 2024-04-19).

“On April 19, 2024, the Company entered into a securities purchase agreement (the “Second Transaction Purchase Agreement”) with certain purchasers, pursuant to which the Company agreed to issue and sell to such purchasers (a) in a registered direct offering, 361,904 shares (the “Second Transaction Shares”) of Common Stock, at an offering price of $5.250 per share, and (b) in a concurrent private placement, common stock purchase warrants (the “Second Transaction Warrants”) exercisable for an aggregate of up to 542,856 shares of Common Stock, at an exercise price of $5.06 per share (the “Second Transaction Warrant Shares”), for aggregate gross proceeds of approximately $1.9 million”

Datavault AI Inc. entered into Initial Transaction Purchase Agreement with certain purchasers valued at aggregate gross proceeds of $750,000 (effective 2024-04-17).

“WiSA Technologies, Inc., a Delaware corporation (the “Company”), closed (the “Closing”) an offering with certain purchasers signatory to that certain securities purchase agreement dated April 17, 2024 (the “Initial Transaction Purchase Agreement”).”